Tong Ting

Quick links to important sections

Tong Ting

Treatment option: Pain, Chronic Pain

Medically reviewed

Laura Arias

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Tong Ting

Property Description
Active ingredient Tramadol Hydrochloride
Form Tablet, Capsule, Oral Solution, Injection
Pharmacological class Opioid Analgesic
General purpose Management of moderate-to-severe pain
Origin Synthetic compound

What Type of Medicine is Tong Ting?

Tong Ting is a synthetic, centrally acting pain relief medication classified pharmacologically as an Opioid Analgesic. Its primary general purpose is the symptomatic management of moderate-to-severe pain. The active ingredient, Tramadol Hydrochloride, is distinct in its class because it utilizes a dual mechanism, interacting with mu-opioid receptors while also inhibiting the reuptake of key neurotransmitters, which contributes to its overall analgesic efficacy.

Tramadol alters the central nervous system's perception of pain. This substance offers a broad-spectrum approach to discomfort, reinforcing the body's natural pain-modulating systems, giving it a unique pharmacological profile among analgesics.

Composition, Origin, and Available Forms

The core component of Tong Ting is Tramadol Hydrochloride, a chemical substance that is entirely synthetic in origin, meaning it is a man-made compound rather than being derived from natural sources. This property is a defining characteristic of its classification.

Tong Ting (Tramadol Hydrochloride) is commonly presented in multiple pharmaceutical preparations to suit different therapeutic needs, such as managing chronic ongoing pain or acute discomfort. It is available for oral administration as immediate-release and extended-release tablets and capsules, and also as a sterile solution for injection. Furthermore, this agent is available both as a single-ingredient product and frequently as a combination product, notably co-formulated with nonopioid pain relievers such as paracetamol (acetaminophen).

What side effects are possible with Tong Ting?

Possible side effects and safety information

Tong Ting (Tramadol Hydrochloride) is associated with a range of officially documented side effects, which are classified by regulatory authorities based on the frequency observed in clinical studies and the body system affected.


Commonly Documented Adverse Reactions

Adverse effects are categorized by incidence. The regulatory label lists several effects as Very Common (occurring in ge 1/10 patients), including nausea, dizziness/vertigo, and constipation. Effects classified as Common (occurring in ge 1/100 to < 1/10 patients) typically include headache, somnolence (drowsiness), vomiting, and sweating (hyperhidrosis).


System-Organ Classification and Serious Risks

Side effects are grouped by System-Organ Class. Gastrointestinal Disorders (constipation, nausea) and Nervous System Disorders (dizziness, headache) are most frequently reported. The label highlights Serious Adverse Reactions that can be life-threatening, such as Respiratory Depression, Serotonin Syndrome, and Seizures/Convulsions, which may occur even within the recommended dosage range. The risk of Addiction, Abuse, and Misuse is also prominently documented.


Safety Patterns and Special Populations

Some safety risks are explicitly tied to the duration of use or patient profile. The risk of respiratory depression increases during treatment initiation or following a dose increase. Long-term use carries a risk of physical dependence and tolerance. Regarding specific populations, the medicine is contraindicated in children younger than 12 years of age and in adolescents younger than 18 years following tonsillectomy or adenoidectomy. Caution is officially mandated for older adults and patients with severe renal or hepatic impairment.

Overdose and Emergency Response

Overdosage of Tong Ting (Tramadol Hydrochloride) is an officially documented medical emergency. The clinical profile is primarily defined by severe central nervous system (CNS) and respiratory depression, both noted as life-threatening manifestations in regulatory documents.

Documented signs of acute overdose include extreme sleepiness progressing to stupor or coma, slow or shallow breathing, miosis (pinpoint pupils), and muscle weakness. Severe outcomes are explicitly documented as respiratory arrest, cardiac arrest, and death. Furthermore, regulatory labeling highlights the specific risk of seizures (convulsions) and the potential for Serotonin Syndrome, especially with concurrent ingestion of other serotonergic agents.

Regulators mandate immediate action for any suspected overdosage. Users are directed to seek emergency medical help immediately due to the risk of life-threatening respiratory and cardiac complications.

Overdose management is symptomatic and supportive. While the opioid antagonist Naloxone may be administered for respiratory effects, official documents caution that its effect may be limited in fully reversing all manifestations, particularly the non-opioid mediated effects. Continuous hospital monitoring of respiratory and cardiovascular function is required following acute overdosage.

Therapeutic Uses of Tong Ting

Tong Ting is commonly used to help with symptoms related to physical discomfort. This supportive therapy is commonly used across conditions presenting with acute episodes, conditions involving inflammatory or irritative processes, or situations where symptoms escalate temporarily.

Its role is relevant across therapeutic domains involving heightened symptom expression, particularly managing symptoms of increased neurological or muscular activity.

“This medication is applied across domains where additional symptomatic support is needed for symptoms that interfere with daily functioning.”

This support assists with maintaining functional stability. It contributes to improved day-to-day comfort and may help patients cope more steadily with difficult episodes.

Quick Fact: Relief for Heightened Discomfort
Tong Ting is applied when appropriate for symptoms that become more disruptive during flare-ups and when additional symptomatic assistance is needed.

Regulatory References

  1. NIH MedlinePlus Drug Information

Eligibility and Restrictions for Use

Tong Ting (Tramadol) eligibility is strictly defined by government regulatory documents, establishing absolute prohibitions and specific restrictions based on patient population and pre-existing conditions.

Contraindicated Populations (Must Not Use)

Category Official Regulatory Classification
Pediatric Use All children younger than 12 years of age are contraindicated.
Post-Operative Use Contraindicated for patients younger than 18 following tonsillectomy and/or adenoidectomy.
Acute Status Patients with significant respiratory depression or acute intoxication with alcohol/other central nervous system (CNS) depressants.
Comorbidities Patients with known hypersensitivity to the drug or opioids, or those using MAO inhibitors (or within the last 14 days).

Populations Requiring Conditional Use

Category Official Regulatory Classification
Organ Function Severe renal or hepatic impairment; use of extended-release formulations is generally not recommended.
Adolescents Use must be avoided in adolescents (12–18 years) with existing risk factors for respiratory depression.
Pregnancy/Lactation Prolonged use during pregnancy carries the risk of Neonatal Opioid Withdrawal Syndrome. Breastfeeding is not recommended.
CNS Risk Use with caution in patients with a history of seizures, increased intracranial pressure, or head injury.

What should I know about interactions with other medicines?

The official interaction profile of Tong Ting (Tramadol Hydrochloride) is defined by mandatory restrictions for specific drug combinations and documented metabolic interference, as stated in governmental regulatory labels.

Interaction Classification and Restrictions

Classification Interacting Agents Regulatory Constraint
Formal Contraindication Monoamine Oxidase Inhibitors (MAOIs), Other Tramadol products Do not co-administer. A 14-day separation period is required after stopping MAOIs before initiating this product.
Pharmacodynamic Risk CNS Depressants (e.g., Benzodiazepines, Alcohol), Serotonergic Drugs (e.g., SSRIs, SNRIs) Restriction is imposed due to the enhanced risk of profound sedation, respiratory depression, or serotonin syndrome.
Pharmacokinetic Alteration CYP2D6 Inhibitors (e.g., Fluoxetine), CYP3A4 Inducers (e.g., Carbamazepine) Co-administration may result in altered exposure: either increased plasma concentration of the parent drug or reduced levels of the active metabolite.

Co-administration with agents that lower the seizure threshold, such as certain antidepressants and antipsychotics, may increase the risk of seizures. The interaction profile also notes that individuals classified as CYP2D6 ultrarapid metabolizers should not use the product, as their increased metabolism results in higher concentrations of the active metabolite, which carries a specific safety risk. The elimination of the drug is also delayed in individuals with severe hepatic or renal impairment, which affects its safe use with other medicines.

Mechanism of Action

mu -Opioid Receptor Agonism and Direct Signal Inhibition

This core mechanism is mediated by the drug’s highly active metabolite, O -desmethyltramadol (M1), which functions as an agonist at the mu -opioid receptor in the central nervous system. This molecular binding initiates an inhibitory G-protein signaling cascade that results in the hyperpolarization of nerve cells. The resultant cellular stabilization inhibits the release of key neurotransmitters involved in nociceptive communication. This action directly reduces the transmission of nociceptive signals from the spinal cord to higher centers, producing an alteration in nociceptive communication.

Monoamine Modulation and Descending Pathway Amplification

The parent compound, Tramadol, provides a complementary mechanism by acting as an inhibitor of the neuronal reuptake of the monoamines norepinephrine and serotonin at their respective transporters. By increasing the concentration of these neurotransmitters in the synaptic cleft, the drug amplifies the body’s descending pain inhibitory pathways. This physiological amplification of natural suppression mechanisms contributes to the overall reduction in responsiveness to nociceptive stimuli.

Complementary Dual-Action and Metabolic Efficacy

The overall physiological effect arises from the complementary action between the direct mu -opioid agonism (M1-mediated) and the indirect monoamine reuptake inhibition (parent drug-mediated). This dual mechanism is fundamentally constrained by the liver enzyme CYP2D6, which is required for the conversion of the parent drug into the M1 metabolite. Individual variability in this enzyme's activity determines the strength of the mu -opioid component, leading to a mechanistically constrained contribution from that pathway in populations with low enzyme activity.

Dosage and Administration Information

Tong Ting (Tramadol Hydrochloride) is administered through multiple official routes, depending on the therapeutic need and available preparation. The medicine is primarily used via oral administration as immediate-release (IR) or extended-release (ER) tablets and capsules, or as an oral solution. It is also approved for parenteral use as a solution for injection, allowing for intravenous, intramuscular, or subcutaneous administration in clinical settings.

Official dosing is structured around the formulation used. For immediate-release tablets or capsules, the dose is typically between 50 mg and 100 mg, taken every 4 to 6 hours as needed, with a maximum daily intake of 400 mg.

For the extended-release forms, administration occurs once daily, with an initial dose often set at 100 mg and a maximum daily dose not to exceed 300 mg. Extended-release tablets and capsules are required to be swallowed whole and must not be split, crushed, or chewed, a constraint designed to preserve the intended time-release mechanism. Oral forms may be taken independently of meal times.

Specific adjustments to the standard regimen are officially mandated for certain populations. The maximum daily dose for immediate-release forms is typically reduced to 300 mg for adults over 75 years of age. Furthermore, patients with severe renal or hepatic impairment require an adjustment of the dosing interval, often extending it to every 12 hours, with some extended-release forms being contraindicated for use in these patient groups.

Recent Clinical Evidence

Evidence for Primary Indications

Research has explored Tong Ting's use across three main areas: chronic non-cancer pain, acute pain, and cancer-related pain. For persistent conditions like osteoarthritis and chronic low back pain, Randomized Controlled Trials ( RCTs) examined outcomes related to physical discomfort and daily functioning. Findings were mixed, with studies reporting small score differences when compared to non-active controls, leading high-level analyses to categorize the evidence base as having low certainty. For acute and post-operative pain, short-term RCTs are more prevalent, and the evidence base for short-term symptom patterns is described as having moderate certainty. For cancer-related pain, randomized evidence is limited and of very low quality, and the clinical implications are not fully established.


Research Gaps and Follow-up Limitations

Most controlled trials used in research exploring how symptoms change over time focused on durations between 4 and 16 weeks. Long-term effects are not fully established by high-quality RCTs; studies covering periods beyond a few months rely mainly on observational reports, which provide limited insight into sustained changes. The overall evidence quality varies, and certainty remains low for many chronic pain outcomes. The small magnitude of measured change observed in some studies contributes to discussions about the clinical relevance of the findings. Comparative evidence against all alternative non-opioid pain strategies is also lacking.


Evidence in Specific Populations

The majority of RCTs were evaluated in the general adult population, with some sub-analyses focused on older adults. Data remains insufficient for pediatric patients, particularly those with cancer-related pain. Findings were mixed when trying to draw conclusions about its use across specific comorbidity groups, and research is ongoing to understand if differences in patient factors may be associated with study outcomes.

Key Studies & References

  1. Tramadol for the Management of Pain in Adult Patients: A Review of Clinical Effectiveness — An Update (CADTH review)
  2. Tramadol - StatPearls Reference

Frequently Asked Questions (FAQ)

Common questions about Tong Ting (FAQ)

Q: Is Tong Ting used for more than one health condition?

According to official product information, Tong Ting is indicated for the management of moderate-to-severe pain. This includes its use across several therapeutic areas, such as chronic pain that is not cancer-related, acute pain (short-term), and certain types of cancer-related pain. Its primary purpose is to address pain symptoms within this severity range.


Q: How quickly can a person expect to feel the general effects of Tong Ting?

Official pharmacokinetic studies indicate that for the immediate-release formulation, the maximum concentration of the drug in the blood plasma typically occurs between 1.6 and 2 hours after administration. The measurement of maximum concentration in the blood plasma (Cmax) is a pharmacokinetic data point, and individual experience may vary.


Q: Are there any common over-the-counter medicines that interact with Tong Ting?

Official regulatory documents warn of potential interactions with any medicine that could affect the CYP2D6 enzyme (used to process the drug) or lower the body's seizure threshold. Because some over-the-counter (OTC) products and supplements may fall into these categories, regulatory information emphasizes the importance of informing a healthcare provider about all concurrent medicines.


Q: Is Tong Ting considered a long-term treatment or short-term?

Clinical trials used for regulatory review typically focused on treatment durations of 16 weeks or less. Consequently, the effects of Tong Ting for periods longer than a few months are not fully established by high-quality studies. Official safety information also notes that long-term use is associated with a risk of developing physical dependence.


Q: How does Tong Ting compare to other standard treatments, generally speaking?

Research into Tong Ting's pharmacological properties reports its pain-relieving potency as being roughly one-tenth to one-sixth that of morphine. Official reviews also state that comprehensive comparative evidence, which examines its efficacy against all alternative non-opioid pain strategies, is noted as limited or lacking.


Q: Is Tong Ting appropriate for use by elderly patients?

Official documents require caution when this medicine is used by older adults. Specifically, the regulatory label mandates a reduction in the maximum daily dose for the immediate-release formulation for patients over 75 years of age due to potential changes in how the body processes the drug.


Q: Has Tong Ting been studied in children or adolescents?

Official guidance states the product is contraindicated (must not be used) in all children younger than 12 years old. For patients in the pediatric age range, research evidence is generally considered insufficient for the product's use, particularly in certain high-risk groups.


Q: Can a person stop taking Tong Ting suddenly?

Regulatory labeling includes a specific warning against sudden discontinuation of Tong Ting, as stopping abruptly may lead to the development of withdrawal symptoms. Official guidance requires that the dose be gradually reduced, or tapered, when the medicine is being stopped.


Q: What happens if a dose of Tong Ting is missed?

Official patient information includes standard guidance regarding missed doses. This information typically states that a forgotten dose should be taken as soon as it is remembered, unless the time for the next scheduled dose is near. In that scenario, the standard guidance is to skip the missed dose and continue with the regular schedule.


Q: Is there a generic version of Tong Ting available?

The active ingredient in Tong Ting, Tramadol Hydrochloride, is a compound that has been approved and is available in generic versions. The availability of generic formulations is subject to the specific drug products approved by the regulatory bodies in the local national market.


Q: What should I do if I think I am experiencing an interaction with Tong Ting?

Official regulatory information requires that if signs of a serious adverse effect or severe interaction are experienced, a person must seek immediate medical attention. This protocol is in place because certain adverse reactions can be life-threatening.


Q: Can Tong Ting be taken with vitamins or dietary supplements?

The official interaction profile focuses on substances that can interfere with the CYP2D6 enzyme or affect serotonin levels in the body. Because some vitamins and dietary supplements may influence these factors, official guidance emphasizes the importance of informing a healthcare provider about all concurrent supplements to check for potential interaction risk.


Q: What kind of evidence is available from research on Tong Ting?

Research evidence for Tong Ting includes several Randomized Controlled Trials (RCTs) that have examined its use in treating both acute and chronic pain conditions. Regulatory reviews categorize the certainty of this evidence as ranging from low to moderate, depending on the specific pain indication being studied.


Q: Is it normal to feel a specific sensation when starting Tong Ting?

Official regulatory documents list several effects as very common (occurring in ge 1/10 patients) when first starting the treatment. These frequently experienced sensations include nausea and dizziness or vertigo.


Q: Are there any special considerations for people with kidney problems using Tong Ting?

According to official product information, there are specific restrictions for patients with kidney problems. Individuals diagnosed with severe renal impairment typically require an adjustment of the dosing interval. In these cases, extended-release formulations are often officially not recommended for use.


Q: Are there any special considerations for people with liver problems using Tong Ting?

Official product information includes special considerations for patients with liver problems. Individuals with severe hepatic impairment (liver function issues) typically require an adjustment of the dosing interval. Extended-release formulations are often officially not recommended in these patient groups.


Q: Do food or certain drinks affect how Tong Ting works?

Official documents state that the oral forms of the medicine are generally described as being able to be taken independently of meal times. However, the co-administration of alcohol is officially contraindicated because of the enhanced risk of profound sedation and serious respiratory side effects.


Q: Why do some people need to take Tong Ting and others do not?

The medicine is officially indicated for the symptomatic management of moderate-to-severe pain. Its use is constrained by this therapeutic classification, meaning it is intended for individuals whose symptoms fall within this defined severity range and who meet all other eligibility criteria.


Q: Does Tong Ting affect a person's ability to drive or operate machinery?

Regulatory documents include a specific warning about the Risk of Driving and Operating Machinery. This is due to common side effects like somnolence (drowsiness) and dizziness that may impair physical and mental abilities necessary for those tasks.


Q: Is Tong Ting known to cause changes in mood or sleep?

Official regulatory documents list somnolence (drowsiness) as a common side effect, which affects sleep patterns. The documents also describe less common side effects involving changes in mood, such as feelings of unusual happiness (euphoria) or dissatisfaction (dysphoria).


Q: What is the typical duration of effect for a dose of Tong Ting?

The elimination half-life of the active ingredient is officially documented as typically being around 6.3 hours. Since it takes approximately five half-lives for a substance to be fully cleared, this figure indicates the general rate at which the medicine is processed and eliminated from the body.


Q: Is Tong Ting safe to take during pregnancy, according to official documents?

Official guidance states that prolonged use during pregnancy carries a risk of Neonatal Opioid Withdrawal Syndrome in the newborn. Due to this risk, use is generally not recommended unless a healthcare provider determines that the potential benefit to the patient justifies the potential risk to the fetus.


Q: Is Tong Ting safe to use while breastfeeding?

Official regulatory documents clearly state that this product is not recommended for use while breastfeeding. This is because the active ingredient and its active metabolite have been shown to transfer into breast milk.


Q: Are there specific symptoms that require contacting a healthcare provider while on Tong Ting?

Official documents list specific, rare, but serious adverse reactions for which regulatory guidance mandates immediate contact with a healthcare professional. These include signs of respiratory depression (shallow or slow breathing) or symptoms indicative of serotonin syndrome.


Q: Does Tong Ting have a 'black box' warning from the FDA or similar agency?

Yes, the U.S. Food and Drug Administration (FDA) requires the labeling to include a prominent Boxed Warning. This warning highlights the most serious safety risks associated with the medicine, such as Addiction, Abuse, and Misuse, life-threatening Respiratory Depression, and Neonatal Opioid Withdrawal Syndrome.


Q: Where can I find the official patient information leaflet for Tong Ting?

Official patient information, often provided in leaflets or package inserts, can be found on authoritative government websites. These sources include the U.S. National Institutes of Health's DailyMed or the national drug information website of the country where the medicine is approved.


Q: How is Tong Ting different from its placebo in clinical trials?

Studies comparing Tong Ting to an inactive control (placebo) in clinical trials have shown that the drug produces pain relief. The documented difference in pain outcomes, measured as a small score difference, varies depending on the specific health condition being treated.


Q: What kind of patient monitoring is typically required when taking Tong Ting?

Official regulatory documents specify that close patient monitoring is required, particularly regarding signs of respiratory depression (slow or shallow breathing). This monitoring is noted as especially important during the initial period of treatment or when the prescribed dose is increased.


Q: What are the most common reasons patients discontinue Tong Ting?

According to data from clinical trials, the most frequent reasons reported by patients for discontinuing the treatment were common side effects. These typically involved nausea, dizziness, and related gastrointestinal discomforts.


Q: Does Tong Ting have a different purpose in different countries?

While the specific approved formulations or therapeutic indications may vary slightly between national regulatory bodies, the core general purpose of the medicine remains the management of moderate-to-severe pain globally.


Q: What are the criteria used by official bodies to approve Tong Ting?

The official approval of Tong Ting is based on several criteria set by regulatory bodies. These include demonstrating efficacy (effectiveness) in controlled trials and establishing a favorable benefit-risk profile for its intended use.


Q: Are there any known issues with Tong Ting and pre-existing heart conditions?

Regulatory documents include warnings about the risk of certain cardiovascular effects. This includes the potential for Severe Hypotension (low blood pressure), and caution is officially advised for use in patients with conditions like circulatory shock.


Q: Do regulatory agencies recommend any specific lifestyle changes while taking Tong Ting?

Regulatory warnings emphasize the importance of avoiding alcohol consumption while using the medicine. Additionally, official information notes the risk associated with performing tasks that require full mental alertness, such as driving or operating machinery.


Q: Does the time of day matter when taking Tong Ting?

Official information regarding formulations taken once daily (extended-release) typically states they should be taken at the same time each day to maintain consistent drug levels. Immediate-release forms, in contrast, are generally taken on an as-needed basis.


Q: Is Tong Ting known to interact with herbal remedies like St. John's Wort?

Official documents caution against co-administration with other substances that may increase serotonin levels in the body. Since some herbal remedies may pose this risk, regulatory guidance emphasizes the need to disclose their use due to the potential for a serious condition called serotonin syndrome.


Q: How long does Tong Ting stay in the body after the last dose?

The elimination half-life of the active ingredient is officially documented as typically being around 6.3 hours. Since it takes several half-lives for a substance to be fully cleared, this figure indicates the general rate at which the medicine is processed and eliminated from the body.


Q: Are there official guidelines for what constitutes an overdose of Tong Ting?

Regulatory documents include a specific section on overdose, describing the major potential effects. These symptoms include severe respiratory depression (slow or stopped breathing), seizures, and the onset of a coma.


Q: Does Tong Ting affect fertility?

Official labeling includes information that animal studies have shown that high doses of the active ingredient may impair fertility. This potential risk is therefore included in the warnings provided in regulatory documents.


Q: Can I get Tong Ting without a prescription?

The active ingredient in Tong Ting is officially classified as a Controlled Substance in many jurisdictions, including the United States (Schedule IV). This classification means the medicine requires a prescription for dispensing and use.


Q: Why are there different strengths of Tong Ting available?

Different strengths of the medicine are made available to support individualized dosing regimens. This allows for a healthcare provider to achieve gradual dose titration (small, controlled changes) to manage moderate-to-severe pain effectively while helping to minimize adverse events.


Q: What is the purpose of the inactive ingredients in Tong Ting?

Inactive ingredients are officially documented in product information and serve functional roles. Their purpose is to stabilize the drug, facilitate absorption, or ensure the medicine takes the correct pharmaceutical form, such as creating an immediate-release or extended-release tablet.


Q: What is the expected timeline for Tong Ting to be fully effective?

The full therapeutic effect is typically achieved after the process of dose titration is completed. This timeline is individualized and is related to how long clinical trials studied the drug's short-term effects, which was often between 4 and 16 weeks.


Q: How does Tong Ting affect blood pressure or heart rate, based on official data?

Severe effects like hypotension (low blood pressure) have been reported. Effects on heart rate are documented in the context of overdose or severe reactions. This risk is related to the overall cardiovascular effects noted in official documentation.


Q: Do clinical studies show that Tong Ting has a sustained effect over time?

Studies and official information indicate that the research evidence for a sustained effect over long periods (beyond a few months) is not fully established by high-quality randomized controlled trials. Most controlled trials were conducted over shorter periods.


Q: Can Tong Ting be taken at the same time as other prescription medications?

Official documents specify that Tong Ting is contraindicated (must not be used) with certain classes of medicines, such as MAO inhibitors. Co-administration with many other prescription drugs mandates that a healthcare provider carefully review the patient's full medication list to manage the risk of serious side effects like Serotonin Syndrome or profound sedation.

How should Tong Ting be stored and disposed of?

Storage Conditions and Environment

Tong Ting (Tramadol Hydrochloride) must be stored at room temperature, generally below 30 C. The product should be protected from freezing, heat, direct light, and moisture. It is required to be kept in a tightly closed container to maintain product quality.

Security and Child Safety

Due to its classification as a controlled substance, this medicine must be stored locked up and securely out of the sight and reach of children to prevent accidental ingestion, which can be fatal.

Disposal Instructions

Unused or expired Tong Ting must be disposed of according to official regulatory guidelines. The recommended procedure is to utilize a drug take-back program. If one is unavailable, the medication must be mixed with an unpalatable substance (like coffee grounds or kitty litter) in a sealed container before being thrown in the household trash. It must not be thrown into wastewater.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Tong Ting found in:

A-Z Index: